Atlas Trials

Development of Agents to Diminish the Risk of Hypoglycemia-induced Brain Injury in Type 1 Diabetes

Clinical trial NCT03356457 · COMPLETED

Trial details

NCT number
NCT03356457
Sponsor
Yale University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Hyperglycaemia (Diabetic)
Start date
2017-11-30
Primary completion
2019-03-20
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.